THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Drug Metabolism And Disposition

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/DMD.104.002592PMID 15743978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.

  2004cited by this paper
• Pharmacokinetics of the anticancer agent 2-chloro-9-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)adenine in rats

  2004cited by this paper
• Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.

  2003cited by this paper
• Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

  2003cited by this paper
• Distribution of 2-chloro-2′-deoxyadenosine, 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, Fludarabine and Cytarabine in mice: a whole-body autoradiography study

  1999cited by this paper
• Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) adenine.

  1996cited by this paper
• Structure-Activity Relationships of 2-Chloro-2′-arabino-fluoro-2′-deoxyadenosine and Related Analogues: Protein Binding, Lipophilicity, and Retention in Reversed-Phase LC

  1995cited by this paper
• Effects of 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5'-triphosphate.

  1991cited by this paper

• In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier

  2023cites this paper
• Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans

  2021cites this paper
• Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

  2017cites this paper
• Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins

  2016cites this paper
• Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study

  2015cites this paper
• Strategies for skeletal muscle targeting in drug discovery.

  2015cites this paper
• Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis

  2014cites this paper
• This information is current as Lymphohistiocytosis Disorder Hemophagocytic Cells To Control the Immunoregulatory Etoposide Selectively Ablates Activated T

  2013cites this paper
• Comparison of the in vitro and in vivo metabolism of Cladribine (Leustatin, Movectro) in animals and human

  2013cites this paper
• Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions

  2012cites this paper
• Pharmacokinetics

  2011cites this paper
• Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer

  2011cites this paper
• New Agents for the Treatment of Acute Lymphblastic Leukemia

  2011influential citation
• The interactions of anti-cancer drugs approved in the last decade in the United States with membrane transporters.

  2010cites this paper
• Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion.

  2010cites this paper
• Clofarabine-induced capillary leak syndrome in a child with refractory acute lymphoblastic leukemia.

  2010cites this paper
• Effect of hemodialysis on the plasma levels of clofarabine

  2010cites this paper
• Clofarabine for the treatment of adult acute myeloid leukemia.

  2009cites this paper
• Mechanisms of anti-cancer action and pharmacology of clofarabine.

  2009cites this paper
• Treating refractory leukemias in childhood, role of clofarabine

  2008cites this paper
• Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma.

  2007cites this paper
• Molecular Modelling Analyses of the Metabolism of Clofarabine

  2007cites this paper
• A Comparison of the Transportability, and Its Role in Cytotoxicity, of Clofarabine, Cladribine, and Fludarabine by Recombinant Human Nucleoside Transporters Produced in Three Model Expression Systems

  2006influential citation
• Discovery and development of clofarabine: a nucleoside analogue for treating cancer

  2006cites this paper